Exploring the Bioactive Constituents and Therapeutic Mechanisms of Sanhuang Xiexin Decoction in Hypercholesterolemia Treatment Using UHPLC-Q-Orbitrap-MS/MS Integrated With Metabolomics and Network Pharmacology

被引:0
作者
Zhu, Yatong [1 ]
Yang, Xinlei [2 ]
Wang, Furong [1 ]
Zhao, Mengting [1 ]
Hong, Junli [2 ]
Zhang, Jun [2 ]
Wang, Lin [1 ]
机构
[1] Yantai Univ, Sch Pharm, Collaborat Innovat Ctr Adv Drug Delivery Syst & Bi, Key Lab Mol Pharmacol & Drug Evaluat,Minist Educ, Yantai, Peoples R China
[2] Nanjing Med Univ, Sch Pharm, Nanjing, Peoples R China
关键词
metabolomics; network pharmacology; Sanhuang Xiexin Decoction; UHPLC-Q-Orbitrap-MS/MS; CARDIOVASCULAR-DISEASE; ACCUMULATION; METABOLITES;
D O I
10.1002/rcm.10035
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
RationalSanhuang Xiexin Decoction (SHD), a traditional Chinese medicine, has been used widely in East Asian Countries for hundreds of years and recent studies have implied its lipid-lowering and cardiovascular protective effects. However, the active components and potential mechanism of SHD in treating hypercholesterolemia (HC) remain unclear.MethodsUHPLC-Q-Orbitrap-MS/MS was used to annotate the components in SHD, and then, the efficacy of SHD in alleviating HC was demonstrated in vitro and in vivo. Subsequently, metabolomics by UHPLC-Q-Orbitrap-MS/MS was employed to identify discriminative metabolites and metabolic pathways involved in SHD against HC. Network pharmacology was applied to explore the potential bioactive components. Then, the integrated approach was proposed to elucidate the possible targets and mechanisms. Finally, molecular docking was operated to validate the potential targets and bioactive components.ResultsA total of 180 chemical components were identified in SHD, and 18 prototype components were confirmed in vivo. Metabolomics study revealed 12 metabolites, and five metabolic pathways were associated with the efficacy of SHD. Network pharmacology analysis further identified 18 active compounds and 107 targets. Finally, the integrated approach suggested that SHD exerts its protective effects against HC by modulating purine and glycerophospholipid metabolism through the regulation of key targets, including phosphodiesterase 5 (PDE5), acetylcholinesterase (ACHE), phospholipase A2 group VII (PLA2G7), and xanthine dehydrogenase (XDH).ConclusionSHD exerts its therapeutic effects on HC through multiple targets and multiple mechanisms. This study lays the groundwork for the clinical application of SHD in the treatment of HC and paves the way for further exploration of its underlying mechanisms.
引用
收藏
页数:20
相关论文
共 42 条
[1]   The pathogenesis of arteriosclerosis [J].
Allen, Edgar V. ;
Merritt, H. Houston ;
Duff, G. Lyman ;
Moore, Robert A. ;
Kendall, Forrest E. ;
Shumacker, Harris B., Jr. ;
Levy, Robert L. ;
Wright, Irving S. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (06) :1791-1793
[2]   Diagnosis and Management of Statin Intolerance [J].
Alonso, Rodrigo ;
Cuevas, Ada ;
Cafferata, Alberto .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2019, 26 (03) :207-215
[3]   Dietary L-arginine intake and the incidence of coronary heart disease: Tehran lipid and glucose study [J].
Bahadoran, Zahra ;
Mirmiran, Parvin ;
Tahmasebinejad, Zhaleh ;
Azizi, Fereidoun .
NUTRITION & METABOLISM, 2016, 13
[4]   The role of xanthine oxidoreductase and uric acid in metabolic syndrome [J].
Battelli, Maria Giulia ;
Bortolotti, Massimo ;
Polito, Letizia ;
Bolognesi, Andrea .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (08) :2557-2565
[5]   Mass spectrometry-based metabolomics in microbiome investigations [J].
Bauermeister, Anelize ;
Mannochio-Russo, Helena ;
Costa-Lotufo, Leticia V. ;
Jarmusch, Alan K. ;
Dorrestein, Pieter C. .
NATURE REVIEWS MICROBIOLOGY, 2022, 20 (03) :143-160
[6]  
BLAKE GH, 1995, AM FAM PHYSICIAN, V51, P1157
[7]   Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews [J].
Byrne, Paula ;
Cullinan, John ;
Smith, Amelia ;
Smith, Susan M. .
BMJ OPEN, 2019, 9 (04)
[8]   PLA2G7: a new player in shaping energy metabolism and lifespan [J].
Candels, Lena Susanna ;
Becker, Svea ;
Trautwein, Christian .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[9]   Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM [J].
Chen, Dan ;
Chen, Xiao ;
He, Cai ;
Xiao, Chuntao ;
Chen, Zelin ;
Chen, Qizhu ;
Chen, Jun ;
Bo, Huaben .
JOURNAL OF ETHNOPHARMACOLOGY, 2023, 306
[10]   A Powerful HPLC-ELSD Method for Simultaneous Determination of Fecal Bile Acids in T2DM Rats Interfered by Sanhuang Xiexin Tang [J].
Chen, Mengjun ;
Liu, Chen ;
Shen, Yumeng ;
Zou, Junfeng ;
Zhang, Zhimiao ;
Wan, Yue ;
Yang, Lei ;
Jiang, Shu ;
Qian, Dawei ;
Duan, Jinao .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2021, 59 (09) :871-876